Peres Center for Peace
Mitchell Blutt serves as the CEO of Consonance Capital, a New York-based healthcare investment firm that controls both a healthcare hedge fund and private equity fund. Beyond his obligations to the company, Mitchell Blutt holds a position on the international board of governors for the Peres Center for Peace. The Peres Center fosters positive relations between people of different cultures through programs such as the Hangout Bridge.
Hangout Bridge focuses on breaking down barriers between Arab and Jewish youth by facilitating communication and building bridges between the two cultures. Targeting relevant communities across the country, the program provides a safe environment for youth from a variety of backgrounds to form lasting friendships. Furthermore, the program builds peace between cultures by integrating online and offline interactions.
The program places youth in groups of eight participants, split equally between Arab and Jewish. Participants collaborate on a joint project though online communications using Google Hangouts and in-person meetings. Projects highlight the potential of shared living in Israel and showcase themes of commonalities, diversity, and intercultural bonding.
New York Academy of Medicine
Mitchell Blutt, MD, is a pioneer in the private healthcare sector, the first doctor to successfully transition from practicing clinical medicine to a role as a professional healthcare investor. Now serving as CEO of Consonance Capital in New York City, Mitchell Blutt, MD is involved in a number of health-related organizations, including the New York Academy of Medicine.
For 22 years, the New York Academy of Medicine has awarded the Rudin Glaucoma Prize to physicians and researchers who demonstrate excellence in studying glaucoma as evidenced by their high-level contributions to peer-reviewed scientific journals. For the 2017 calendar year, the academy chose Mary Kelly, PhD, of Oregon Health & Science University as its winner, recognizing her paper titled, “Induced Pluripotent Stem Cells Restore Function in a Human Cell Loss Model of Open-Angle Glaucoma.”
The groundbreaking research discussed in this article is the first to show that stem cells can be used to deal with the baseline biological causes of glaucoma. Standard treatment manages the symptoms, but the use of stem cells could potentially give doctors a way to reverse the condition instead.
Rock ‘n’ Roll Marathon Series
The first physician to launch a successful career in the healthcare investment sector, Mitchell invests in healthcare companies as the founder of Consonance Capital in New York. Mitchell Blutt also formerly served on the board of directors for the Michael J. Fox Foundation, which welcomes members of the public to contribute toward finding a cure for Parkinson’s by joining Team Fox for athletic events such as the 2017 Rock ‘n’ Roll Marathon Series.
The Rock ‘n’ Roll Marathon Series began with the simple idea of a marathon with bands positioned along the course to cheer on participants. Celebrating its 20th year, the event has grown into a nationwide series of marathons consisting of a weekend of entertainment and runs to support participating charities. The world-class Health and Fitness Expo takes place alongside the marathon. The event concludes with a concert featuring big name musical performers.
Team Fox will participate in two upcoming marathons in the 2017 Rock n’ Roll Series: one in Brooklyn, New York, on October 14 and one in San Antonio, Texas, on December 2 through December 3. Runners who become a member of Team Fox will receive guaranteed entry into the race, running singlet for race day, and a personal fundraising page. Runners must commit to a specific fundraising goal based on race participation and those who meet their goal will receive a commemorative medal.
Addiction Speaker Series
Mitchell Blutt, MD, is CEO and founder of Consonance Capital , a healthcare investment firm based in New York City. Dr. Mitchell Blutt also serves as a clinical assistant professor at Weill Cornell Medical College and is a former member of the advisory board for CASA, The National Center on Addiction and Substance Abuse.
CASA, founded in 1992, strives to “connect science with policy and practice” in the field of addiction and substance abuse, with the ultimate goal of improving the lives of those afflicted both directly and indirectly by this destructive illness.
To date, CASA researchers have published more than 200 articles on substance abuse and addiction. In addition, the organization is dedicated to keeping the public informed on the importance of preventing substance use by children, and the misunderstood nature of addiction, which is often seen as a choice rather than an illness. CASA also highlights nationwide shortcomings such as the mere two cents of every dollar of federal spending received each year for addiction prevention and treatment.
The organization’s Addiction Speaker Series brings in experts whose talks on topics as diverse as “Digital Interventions to Reduce Problem Substance Use” and “Adolescent Substance Misuse Prevention” are available both live at CASA’s New York office, and as webinars. The series is free but the live events require registration.